In recent years, the rapid development of synthetic biology has had a profound impact on life science research and industrial biotechnology. Especially in the construction of microbial cell factories to biosynthesize biofuels, chemicals, and other products, it shows great application prospects. Among them, Fungal Chassis Cells have many advantages as heterologous expression hosts, such as a clear genetic background, a strong ability to secrete proteins, and moderate glycosylation.
Here, with cutting-edge synthetic biology technology, CD BioGlyco has constructed a comprehensive Chassis Cell Platform to provide high-quality Kluyveromyces engineering service, as well as a wide range of Glycobiomolecule Production Services to clients.
CD BioGlyco builds on known metabolic networks and recombinant DNA technology to improve Kluyveromyces chassis cell performance by designing synthetic biology functional elements to precisely regulate metabolic pathways.
Promoter and terminator
We increase the yield of exogenous products in Kluyveromyces chassis cells by constructing and screening for strong promoters and terminators.
Signal sequence
The selection of suitable signaling sequences is an important part of the efficient synthesis of endogenous/exogenous proteins in Kluyveromyces chassis cells. We provide a stable and reliable solution for the efficient expression of heterologous proteins by developing universal and efficient secretion signal sequences.
Selection marker
In the Kluyveromyces genetic manipulation system, we chose nutrient-deficient phenotypes and drug resistance as screening markers. Among them, the utilization of nitrogen-derived screening markers is an important specific screening scheme in Kluyveromyces. Such as URA3, LEU2, and TRP1 are ideal markers for screening Kluyveromyces positive transformants.
During metabolic engineering and synthetic biology modification, genetic modification of multiple genes is usually involved. Therefore, efficient gene editing technologies are essential tools for metabolic engineering and synthetic biology.
Targeted gene integration technology
Integration of exogenous DNA fragments into the genome of microbial chassis cells requires the aid of its double-strand break (DSB) repair mechanism. These include both homologous recombination and non-homologous end-joining repair mechanisms.
Homologous reorganization
Homologous recombination integration of exogenous genes mainly relies on the RAD52 gene cluster, including the genes RAD50, RAD51, RAD52, and XRS2, which can achieve precise targeted integration of exogenous genes in the chassis cell genome.
Non-homologous end joining
We improve the efficiency of Kluyveromyces heterologous gene targeting by knocking down the KU80 gene that mediates the non-homologous end joining of heterologous genes.
Technology: CRISPR-Cas9 technology
Journal: mBio
IF: 6.4
Published: 2018
Results: In this research, the authors created a new synthetic biology platform centered on the thermotolerant yeast Kluyveromyces marxianus. The authors used CRISPR-Cas9-mediated genome editing to show wild isolates of Kluyveromyces marxianus. The authors then engineered the Kluyveromyces marxianus strain to improve lipid production by combining three complex traits with exogenous DNA into a single host.
Fig.1 Gene editing in Kluyveromyces marxianus. (Cernak, et al., 2018)
CD BioGlyco has rich experience in the field of synthetic biology and is capable of performing comprehensive chassis cell designs and applications. We are committed to providing multiple experimental programs to meet our clients' R&D needs. Please feel free to
and we will answer any questions you may have.Reference